No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Aged
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Asia, Eastern
-
Asia, Southeastern
-
Asia, Western
-
Asian People
-
Cause of Death
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
-
Diuretics / therapeutic use
-
Female
-
Heart Failure / complications
-
Heart Failure / drug therapy*
-
Hospitalization / statistics & numerical data*
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Insulin / therapeutic use*
-
Male
-
Metformin / therapeutic use*
-
Middle Aged
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Mortality*
-
Practice Patterns, Physicians' / statistics & numerical data
-
Proportional Hazards Models
-
Registries
-
Stroke Volume
-
Sulfonylurea Compounds / therapeutic use*
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Dipeptidyl-Peptidase IV Inhibitors
-
Diuretics
-
Hypoglycemic Agents
-
Insulin
-
Mineralocorticoid Receptor Antagonists
-
Sulfonylurea Compounds
-
Metformin